Head of Interventional Psychiatry & Neuromodulation

Psychedelic Alpha; Myrtle Point (OR); Presencial; USD 252 000 - 315 000; Tempo integral

Vantagens oferecidas por esta oferta de emprego

Competitive bonus plan

Equity potential

Comprehensive benefits

Resumo da oferta

LifeStance Health in the United States seeks a psychiatrist leader to serve as a clinical authority on neuromodulation and psychedelic therapies, guiding safe, evidence-based program development across the enterprise.

You will design protocols, training models, quality standards, and outcome measures, partnering with Medical Leadership, Clinical Operations, and Compliance to scale interventional psychiatry while ensuring patient safety and regulatory alignment.

Qualificações

• MD or DO with board certification in Psychiatry.
• Active, unrestricted medical license.
• 10+ years of psychiatric clinical experience.
• Excellent written and verbal communication skills.

Responsabilidades

• Design and implement enterprise interventional psychiatry strategy (TMS, pharmacotherapies).
• Lead clinical program development for psychedelic therapies in line with FDA guidance.
• Evaluate emerging treatments for safety, feasibility, and patient need.
• Monitor literature and inform strategy and competitive positioning.
• Oversee training, credentialing, and quality standards for clinicians.

Conhecimentos

Executive communication

Leadership

Stakeholder collaboration

Clinical protocol development

Formação académica

MD or DO in Psychiatry

Descrição da oferta de emprego

LifeStance Health in the United States seeks a psychiatrist leader to serve as a clinical authority on neuromodulation and psychedelic therapies, guiding safe, evidence-based program development across the enterprise.

You will design protocols, training models, quality standards, and outcome measures, partnering with Medical Leadership, Clinical Operations, and Compliance to scale interventional psychiatry while ensuring patient safety and regulatory alignment.